[Calcium antagonists. Pharmacology and clinical pharmacology].
Lehrstuhl für Pharmakologie und Klinische Pharmakologie, Universität Regensburg.
H
H
Grobecker
D000818:Animals; D001682:Biological Availability; D002121:Calcium Channel Blockers / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008657:Metabolic Clearance Rate / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D013329:Structure-Activity Relationship
D002121:Calcium Channel Blockers; D015220:Calcium Channels
Calciumantagonisten. Pharmakologie und klinische Pharmakologie.